An integral yet sometimes overlooked component of a successful drug launch is the development of a comprehensive medical communications plan

The growing need for mental health services in the United States has become increasingly urgent...

As the end of 2024 quickly approaches, we wanted to take a moment to reflect on all that has happened over the course of this year...

Organizations are moving to the approval readiness meeting, a model that lets them make field teams productive on Day One...

Setting clinical trial teams up for success means giving them the resources they need to effectively collaborate and engage ...

Now that we're a bit removed from the COVID-19 crisis, let’s consider some key takeaways from a few relevant stakeholders...

Based on our own qualitative primary research conducted with payers, we have an idea on what is keeping them up at night.

As 2023 comes to a close and 2024 sits on the horizon we wanted to take a moment to look ahead to all that may be in store.

There is a lot to accomplish during the post-launch period to ensure a product's success. Here are 6 key priorities to keep top of mind.

It’s not news that the United States has an obesity problem. However, newer medications are the first truly effective obesity treatments...

A company's publication plan is one of the most important elements of a medical communication strategy ...

The FDA released new draft guidelines for their accelerated approval process, learn what they are and why they're being created ...

We've been thankful this past year for our continued growth and success, our ability to give back, and the innovation we see in healthcare.

While Digital Therapeutics offer great promise and renewed hope to improve patient outcomes, they need to overcome several challenges...

Through PPMI we could change everything about how brain diseases like PD are diagnosed, treated, and ultimately, prevented...

Patient-centric communications encourage reaching individuals with the information that they need in a form that they can use. See how ...